Baidu
map

广东省中医药局印发文件,要求进一步弘扬岭南中医药文化

2017-10-26 中国中医药报记者张斯文 中国中医mp

日前,广东省中医药局发布《关于印发广东省中医药文化推进行动计划(2017—2020年)的通知》。通知要求,进一步弘扬岭南中医药文化,系统推进该省中医药健康养生文化创造性转化,创新性发展,推动广东中医药“大医精诚”理念、“精诚文化”品牌深入人心,使广东省中医药文化建设走在全国前列。通知提出,打造一个“精诚文化”品牌、创作推出一系列中医药文化精品、全面启动一项全省性中医药文化活动、组建一批中医药文化队

日前,广东省中医药局发布《关于印发广东省中医药文化推进行动计划(2017—2020年)的通知》。通知要求,进一步弘扬岭南中医药文化,系统推进该省中医药健康养生文化创造性转化,创新性发展,推动广东中医药“大医精诚”理念、“精诚文化”品牌深入人心,使广东省中医药文化建设走在全国前列。

通知提出,打造一个“精诚文化”品牌、创作推出一系列中医药文化精品、全面启动一项全省性中医药文化活动、组建一批中医药文化队伍、建设一系列中医药文化宣传阵地、打造一批具有鲜明文化特色的中医院、开展一系列专项工作等7项重点工作任务。

通知要求,通过持续开展“弘扬大医精诚践行核心价值”广东中医药先进典型人物事迹报告会,把大医精诚的心灵震撼传递到全省各地。大力宣传国医大师,全国、省级名中医优秀事迹,深化经典学习,树立职业精神。举办中医经典大赛,重温中医经典,营造学习经典,不忘初心的良好氛围。

通过拍摄中医药纪录片《悬壶岭南》《秘境神草》及《世界中医》,制作中医药动漫《本草药灵》、中医药手机游戏《药王之王》,创作广东中医药代表歌曲,编撰岭南中医药文化丛书,实施南粤大医、岭南名医视频拍摄项目等形式,传播广东省优秀的中医药文化,展现中医名家魅力。

通知中特别强调, 9月3日中医中药中国行——广东省中医药健康文化推进行动启动仪式已举办,10月30日前各地级以上市均要举办本市(区)启动仪式。启动仪式现场可同步开展“服务百姓健康行动”大型义诊活动,通过健康咨询、中医药健康文化知识展览展示、中医药体育活动表演、中医药健康服务体验、中医药文化产品展示等方式,推广中医药的理念、知识、方法和产品,提升群众获得感,为中医药事业发展营造良好氛围。

为保障通知内容的更好落实,通知还提出加大中医药文化建设投入,建立中医药文化专家库,将中医院员工诵读经典、医院文化环境建设等列入医院等级评审指标体系、广东省中医名院评价指标体系,建立中医院设计方案汇报评价制度等4项保障措施。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1900126, encodeId=40bd1900126a9, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Fri Feb 02 08:18:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077158, encodeId=34a620e7158ed, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Nov 07 14:18:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744329, encodeId=8eba1e4432970, content=<a href='/topic/show?id=edef215328f' target=_blank style='color:#2F92EE;'>#中医药文化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21532, encryptionId=edef215328f, topicName=中医药文化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=985b35357650, createdName=doctorzheng, createdTime=Tue Aug 07 08:18:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409135, encodeId=00b414091358f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 12:18:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256326, encodeId=85b0256326bc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Fri Oct 27 08:25:32 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2018-02-02 3631173
  2. [GetPortalCommentsPageByObjectIdResponse(id=1900126, encodeId=40bd1900126a9, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Fri Feb 02 08:18:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077158, encodeId=34a620e7158ed, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Nov 07 14:18:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744329, encodeId=8eba1e4432970, content=<a href='/topic/show?id=edef215328f' target=_blank style='color:#2F92EE;'>#中医药文化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21532, encryptionId=edef215328f, topicName=中医药文化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=985b35357650, createdName=doctorzheng, createdTime=Tue Aug 07 08:18:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409135, encodeId=00b414091358f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 12:18:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256326, encodeId=85b0256326bc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Fri Oct 27 08:25:32 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1900126, encodeId=40bd1900126a9, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Fri Feb 02 08:18:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077158, encodeId=34a620e7158ed, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Nov 07 14:18:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744329, encodeId=8eba1e4432970, content=<a href='/topic/show?id=edef215328f' target=_blank style='color:#2F92EE;'>#中医药文化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21532, encryptionId=edef215328f, topicName=中医药文化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=985b35357650, createdName=doctorzheng, createdTime=Tue Aug 07 08:18:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409135, encodeId=00b414091358f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 12:18:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256326, encodeId=85b0256326bc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Fri Oct 27 08:25:32 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1900126, encodeId=40bd1900126a9, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Fri Feb 02 08:18:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077158, encodeId=34a620e7158ed, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Nov 07 14:18:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744329, encodeId=8eba1e4432970, content=<a href='/topic/show?id=edef215328f' target=_blank style='color:#2F92EE;'>#中医药文化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21532, encryptionId=edef215328f, topicName=中医药文化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=985b35357650, createdName=doctorzheng, createdTime=Tue Aug 07 08:18:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409135, encodeId=00b414091358f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 12:18:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256326, encodeId=85b0256326bc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Fri Oct 27 08:25:32 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-28 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1900126, encodeId=40bd1900126a9, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Fri Feb 02 08:18:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077158, encodeId=34a620e7158ed, content=<a href='/topic/show?id=af892152021' target=_blank style='color:#2F92EE;'>#中医药局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21520, encryptionId=af892152021, topicName=中医药局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Tue Nov 07 14:18:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744329, encodeId=8eba1e4432970, content=<a href='/topic/show?id=edef215328f' target=_blank style='color:#2F92EE;'>#中医药文化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21532, encryptionId=edef215328f, topicName=中医药文化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=985b35357650, createdName=doctorzheng, createdTime=Tue Aug 07 08:18:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409135, encodeId=00b414091358f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Oct 28 12:18:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256326, encodeId=85b0256326bc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Fri Oct 27 08:25:32 CST 2017, time=2017-10-27, status=1, ipAttribution=)]
    2017-10-27 小铭的皮普

    学习了

    0

相关资讯

粤人民医院DSA杂交手术室投入使用

广东省首家DSA杂交手术室已在省人民医院心外科投入使用,为医院外科系统及多学科协作的发展创造了良好的条件。自启用以来,由心外科、放射科、麻醉科、心内科、心儿科、手术室护士组成的介入手术治疗团队相互配合、相互协作,已在此手术间内成功为2例B型主动脉夹层患者同期施行弓上分流手术和主动脉腔内隔绝手术,为1例法鲁氏四联症患儿同期施行四联症根治术和肺侧支循环封堵术,为1例A型主动脉夹层患者同期施行Benta

广东省中山市印发全新评审要求

近日,广东省中山市人社局印发了《中山市社会医疗保险定点零售药店 评定项目及量化评分标准表(2017年版)》 和《中山市社会医疗保险定点医疗机构 综合评定项目及量化评分标准表 (2017年版)》的通知(以下均简称《标准表》),于2017年5月28日起实施。

广东省局启用食药许可电子证照

近日,广东省食品药品监管局正式上线食品药品许可电子证照系统,实现“网上申报、网上受理、网上审评、网上审批、网上制证”,做到行政许可全程“零纸张”、申请人办事全程“零跑动”,足不出户即可申办许可证件,扫除无纸化审批发证的“最后一道关口”。

广东省召开名中医表彰大会,国家、省级名中医已达300余人

10月24日,第四届广东省名中医表彰大会在广州召开。广东省副省长邓海光表示,广东将加快推进中医药强省建设,将中医药工作融入深化医改大局。据悉,目前广东省的国家和省级名中医已达300多人。

Baidu
map
Baidu
map
Baidu
map